Skip to main content
Premium Trial:

Request an Annual Quote

That's What They Said About Banking

The president and CEO of the Biotechnology Industry Organization, James Greenwood, tells the Boston Globe that the biotech companies will, for the most part, survive the recession. As a whole, he says, the industry has just started to make money, though because of the economy, there is a risk of some companies losing out. Greenwood also discusses generic biologics and data exclusivity as well as healthcare reform. The R&D Direction Insider blog adds that regarding biosimilars, "it's hard to imagine a soon-to-be compromise that some are predicting."

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.